Feed aggregator

Transthyretin amyloid cardiomyopathy (ATTR-CM) is an increasingly recognized yet frequently underdiagnosed cause of heart failure, particularly among older adults.

MIT engineers have developed a new way to amplify the T-cell response to mRNA vaccines - an advance that could lead to much more powerful cancer vaccines and stronger protection against infectious diseases.

Seasonal influenza can spread rapidly, and timely information on rising cases is essential for public health decisions and healthcare resource planning.

For female participants with myasthenia gravis, pregnancy is not associated with an increased risk of serious flare-ups of the disease, or new or worsening symptoms, according to a study published May 13, 2026, in Neurology, the medical journal of the American Academy of Neurology.

Mayo Clinic researchers have identified an immune-regulating molecule that may help explain why some patients with inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, do not respond to commonly used therapies.

A Lancet Health Policy paper reports an international consensus process that selected polyendocrine metabolic ovarian syndrome (PMOS) as the new name for polycystic ovary syndrome (PCOS). The change aims to shift the focus away from ovarian cysts and better reflect the condition’s endocrine, metabolic, and ovarian features.

New research presented at this year's European Congress on Obesity in Istanbul, Turkey (12-15 May) shows that higher body mass index (BMI) is associated with more financial problems, loneliness, and stress.

In a world first, a research team at the University of Zurich has successfully treated mice carrying an inherited form of epilepsy.

In theory, hypertension is a disease that is both easy to test for and readily treatable with existing medications and lifestyle interventions.

Research has found that children with higher genetic susceptibility to schizophrenia show decreases in frontal cortical surface area during early adolescence, in contrast to the regional expansion observed in children with low genetic susceptibility.

New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London has highlighted the distinct and shared molecular pathways linking cannabis use disorder (CUD) and psychosis, offering the potential for identifying those at risk, as well as targeted interventions for cannabis related psychosis.

Integrated gut microbiome and plasma metabolomics profiling identified distinct microbial and metabolic signatures in people with T2DM and T2DM-CAD. In a small exploratory cohort, Bacteroides sp._CAG_875 and 12-ketoLCA emerged as candidate markers that may help distinguish diabetic patients with coronary complications, pending larger validation.

Oral orforglipron helped adults maintain clinically meaningful weight loss after prior injectable tirzepatide or semaglutide therapy. The phase 3b ATTAIN-MAINTAIN trial suggests switching to once-daily oral therapy may help reduce weight regain when injectable treatment is discontinued.

A recent study conducted at the University of Jyväskylä investigated the emotions evoked by physical activity and what motivates people across different weight groups to exercise.

We feel more anxious when facing uncertain or unpredictable situations, but for those who score higher on autistic traits, this anxiety tends to be stronger.

Up to half of all women will experience some degree of pelvic organ prolapse in their lifetime. The condition can cause incontinence, constipation and the descent of the bladder or uterus into the vagina.

New research presented at this year's European Congress on Obesity in Istanbul, Turkey, shows that use of obesity drugs alongside behavioral interventions leads to a larger drop in so called 'food noise' than in those using the behavioral therapy alone.

Major Depressive Disorder (MDD) is far from a cookie-cutter diagnosis. Different patients report suffering from different subsets of symptoms, yet most are ultimately prescribed the same first-line treatments - typically selective serotonin reuptake inhibitors (SSRIs)- regardless of their individual experience.

Using ultrasound to stimulate a specific part of the brain could offer a non-invasive therapy that benefits those experiencing chronic pain, a new study has suggested.

Inside a world-leading deep brain stimulation program at The Hospital for Sick Children (SickKids), researchers have discovered a brain signal that predicts when a child is about to lose attention - and that a brief, targeted intervention in response to that signal can restore their focus.